| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PCGF4 |
| Uniprot No | P35226 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-250aa |
| 氨基酸序列 | MHRTTRIKITELNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETSKYCPICDVQVHKTRPLLNIRSDKTLQDIVYKLVPGLFKNEMKRRRDFYAAHPSADAANGSNEDRGEVADEDKRIITDDEIISLSIEFFDQNRLDRKVNKDKEKSKEEVNDKRYLRCPAAMTVMHLRKFLRSKMDIPNTFQIDVMYEEEPLKDYYTLMDIAYIYTWRRNGPLPLKYRVRPTCKRMKISHQRDGLTNAGELE |
| 预测分子量 | 56.4 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PCGF4(Polycomb Group RING Finger 4)重组蛋白的3篇代表性文献及其摘要概括：
---
1. **文献名称**：*Structural basis for PRC1 assembly and targeting by Polycomb-like proteins*
**作者**：Endoh, M., et al.
**摘要**：本研究解析了PCGF4与PRC1复合物的相互作用结构，阐明了其通过RING结构域介导的泛素化活性。利用重组PCGF4蛋白，揭示了其在招募PRC1至染色质靶点中的关键作用，为Polycomb介导的表观遗传沉默机制提供结构基础。
2. **文献名称**：*PCGF4 regulates pluripotency in embryonic stem cells through histone ubiquitination*
**作者**：Wang, H., et al.
**摘要**：通过重组PCGF4蛋白的功能实验，证明其与RING1B协同催化组蛋白H2A的泛素化，维持胚胎干细胞多能性。研究显示，PCGF4缺失导致PRC1复合物功能异常，影响干细胞分化潜能。
3. **文献名称**：*Recombinant PCGF4 facilitates high-throughput screening for Polycomb inhibitors in cancer*
**作者**：Li, Y., et al.
**摘要**：开发了一种高效表达重组PCGF4蛋白的方法，并基于其泛素连接酶活性建立药物筛选平台。该研究为靶向Polycomb复合物的抗癌药物开发提供了技术支撑。
---
**备注**：以上文献信息为示例性质，实际引用时建议通过PubMed或Google Scholar核对最新研究，并补充具体发表年份及期刊信息。
**Background of PCGF4 Recombinant Protein**
PCGF4 (Polycomb Group RING Finger Protein 4), also known as BMI1 (B-cell-specific Moloney murine leukemia virus integration site 1), is a critical component of the Polycomb Repressive Complex 1 (PRC1), a key epigenetic regulator involved in maintaining transcriptional repression of genes. As a member of the Polycomb group (PcG) family, PCGF4 plays a vital role in chromatin remodeling and gene silencing, particularly during development, stem cell maintenance, and cellular differentiation.
Functionally, PCGF4 contributes to PRC1’s E3 ubiquitin ligase activity, which catalyzes the monoubiquitination of histone H2A at lysine 119 (H2AK119ub). This modification facilitates chromatin compaction, leading to the stable repression of target genes, including tumor suppressors and differentiation-promoting genes. PCGF4 is essential for self-renewal in stem cells and progenitor cells, and its dysregulation is implicated in cancer progression, where overexpression often correlates with poor prognosis, therapy resistance, and metastasis in malignancies like glioblastoma, breast cancer, and leukemia.
Recombinant PCGF4 protein is produced in vitro using expression systems (e.g., *E. coli* or mammalian cells*) to study its biochemical interactions, structural properties, and role in PRC1 assembly. It enables researchers to explore mechanisms of epigenetic regulation, screen for inhibitors in cancer therapy, or model diseases linked to PcG dysfunction. Studies using recombinant PCGF4 have also shed light on its partnership with other PRC1 subunits (e.g., RING1B) and its crosstalk with PRC2. another Polycomb complex that methylates histone H3K27.
Overall, PCGF4 recombinant protein serves as a valuable tool for dissecting Polycomb-mediated gene silencing and developing targeted epigenetic therapies.
×
